Three Keys in Drafting a China Contract That Works

By | China Law Blog | April 28, 2017
China licensing lawyersIn deleting emails I came across this one from one of our China lawyers to a Latin American client for whom we very successfully drafted a China licensing agreement. I love the email because it so nicely encapsulates exactly what we try to do with pretty much every China contract we draft: balance out everything and give our clients a contract that will both protect them and get the deal done. View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

Attorney Who Would Not Take Case Sued for Not Taking Case

In what appears to us to be a novel theory of law, Plaintiff in Olabopo v Scola   2017 NY Slip Op 30826(U)   April 21, 2017   Supreme Court,   New York County Docket Number: 157461/2016   Judge: Robert D. Kalish seems to be suing because Defendant attorneys did not take the case.   View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

Perrin Conferences May 15 Webinar: JURORS, GENOMICS AND TORT LITIGATION WEBINAR: BREAKING DOWN THE SCIENCE OF GENOMICS FOR JURORS, ATTORNEYS AND THE BENCH

By | GlobalTort | April 28, 2017
Researchers continue to identify more and more genes that appear relevant to development of mesothelioma. Are you experts and trial team ready? If not, consider the upcoming webinar described below. JURORS, GENOMICS AND TORT LITIGATION WEBINAR: BREAKING DOWN THE SCIENCE OF GENOMICS FOR JURORS, ATTORNEYS AND THE BENCH Monday, May 15, 2017 2:00 – 3:30pm EST Topics to be covered: Overview of tort cases where genomic evidence is being used Basic explanation of DNA mutations and why they matter Analysis of jury interest in genetic information Analysis of talking to juries about “alternative causes” Plaintiff – defense counterpoint on the changing role of epidemiology Plaintiff- defense counterpoint on talking about what happened (or not) with cancer in one particular person Costs related to genetic analysis Speakers: Kirk T. View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

The Week in Weed: April 28, 2017

By | The Blunt Truth | April 27, 2017
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. Intense competition for state-issued medical marijuana licenses necessitates advance preparation (Crain’s Cleveland Business: Breaking News, 26 April 2017) It took Ohio years to legalize the production and sale of marijuana for medical purposes. View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

Petition Summary: Large Civil Aircraft from Canada

airplaneOn April 27, 2017, Petitioner The Boeing Company filed a petition for the imposition of antidumping and countervailing duties on imports of 100-to 150-Seat Large Civil Aircraft from Canada. SCOPE OF THE INVESTIGATION The merchandise covered by this petition is aircraft that have a standard 100- to 150-seat two-class seating capacity and a minimum 2,900 nautical mile range, as these terms are defined below. View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

Washington State Passes New Legislation On Collection and Use of Biometric Identifiers

On April 18, 2017, the state of Washington passed House Bill 1493 (“HB 1493”), which sets forth requirements for businesses who collect and use biometric identifiers for commercial purposes. Under HB 1493, a biometric identifier includes a fingerprint, voiceprint, retina, iris or other unique biological pattern or characteristic used to identify a specific individual. View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

PLI Seminar: Private Placements and Hybrid Securities Offerings 2017

By | MOFO Jumpstarter | April 27, 2017
May 22 – 23, 2017 PLI New York Center 1177 Avenue of the Americas (2nd Floor) New York, NY 10036 PLI’s Private Placements and Hybrid Securities Offerings 2017 conference is designed for corporate and securities attorneys, compliance professionals, control room personnel, bankers and allied professionals who deal with private placements and other exempt and hybrid offerings. View Full Post
Tweet Like LinkedIn LinkedIn Google Plus